Abstract
Up to now, treatment of diabetic polyneuropathy remains unsatisfactory. Nevertheless, new pathogenetic concepts about the possible reasons for the development of diabetic neuropathy create new therapeutic approaches to the disease. The following article reviews the therapeutic agents commonly used. Furthermore some new substances are reported which interfere in the pathogenetic pathway of diabetic neuropathy and might be beneficial for the patients suffering from this neuropathy in the future.
Translated title of the contribution | Therapy of diabetic polyneuropathy - Present and future perspectives |
---|---|
Original language | German |
Pages (from-to) | 452-457 |
Number of pages | 6 |
Journal | Nervenheilkunde |
Volume | 17 |
Issue number | 10 |
State | Published - Dec 1998 |
Externally published | Yes |
Keywords
- Diabetic polyneuropathy
- Pathogenetics
- Treatment